Canbiola Begins Deployment of CBD Vending Machines at Select Locations
December 16 2019 - 8:15AM
InvestorsHub NewsWire
Canbiola Begins Deployment of CBD Vending Machines at Select
Locations
HICKSVILLE, NY --
December 16, 2019 -- InvestorsHub NewsWire
-- Canbiola, Inc.
(OTCQB:CANB)
(“Canbiola” or the “Company”), adeveloper, manufacturer, and seller of a variety of
hemp-derived THC-Free Cannabidiol (CBD) Isolate products such as
oils, drops/tinctures, creams, moisturizers, chews, and capsules,
announced today the deployment of the first 10 Canbiola-branded CBD
product dispensing machines.
As previously
announced, the initial focus of this new direct-to-consumer
marketing strategy will be to place the product dispensing machines
in MRI Centers, outpatient surgery centers, urgent and emergency
care facilities, physician offices, high traffic shopping malls,
fitness and health clubs, country club golf pro-shops, and even
high-end hotels. Each product dispensing machine will dispense a
variety of up to 10 of Canbiola CBD products (SKU’s) including hemp
oil drops, CBD salve and CBD Cryo Gel. The product dispensing
machines include a video screen with an explanation of CBD, a
doctor interview/tutorial on the potential applications of CBD and
certificate of analysis (COA) for each product being
sold.
The sale and
demographic data from the first 10 units placement will be used to
gather and analyze data to dictate the placement of the planned
deployment of up to 150 units in
2020.
CanbiolaChief
Executive Officer, Marco Alfonsi, commented, “The deployments of
the Canbiola branded CBD machines will not only increase revenue
but based on the placement in high visibility locations will
dramatically increase brand awareness and allow consumers to learn
about CBD and place orders in an environment outside of the
internet or a traditional retail
store.”
In other news, the
company announced that Green Grow Farms, for which the Company has
signed a definitive acquisition agreement to acquire 51% of, has
signed a national Dealer agreement with “The Triminator” to re-sell
their full line of Hemp Industry products inclusive of harvesters,
trimmers, dryer, buckers and other related products. After much
research, Green Grow has determined The Triminator manufactures
some of the best equipment on the market today, equipment that
Green Grow will be using in its operations as well reselling to
customers primarily in the North East Region of the United
States.
Green Grow Farms is
positioning itself for 2020 to, in addition to growing, being a
full-service provider for the Hemp Growing Community in the
Northeast Region of the United States, providing the best in
harvesting, bucking, drying, curing, trimming and processing. Green
Grow intends to make the capital commitment to build the required
infrastructure to provide turnkey solutions for all the
aforementioned services to the Hemp Growers of the Northeast for
2020. Green Grow will continue to partner with or develop the
finest array of automated equipment for the Hemp
Industry.
For additional
information on Green Grow Farms, please
visit: https://www.greengrowfarmsinc.com/.
(The Company is not
responsible for and does not certify any of the information
contained on Green Grow’s website.)
About Canbiola,
Inc.
Canbiola, Inc.
(OTCQB: CANB) is a
vertically integrated conglomerate specializing in the
manufacturing, formulation and sale of THC-Free Cannabidiol (CBD)
Isolate products such as oils, drops/tinctures, gels, creams,
moisturizers, chews, and capsules. All Canbiola products are
organic and Non-GMO, free of impurities and contaminants, and
formulated with the finest ingredients to the highest manufacturing
standards. All products are certified for purity and accuracy by
third-party laboratory
verification.
Canbiola pursues an
aggressive growth strategy through the continual development of
proprietary products and the expansion of its offerings via
strategic acquisitions in the healthcare and CBD
industries.
Canbiola has created
several innovative CBD product lines, marketed through targeted
channels including:
The Canbiola clinical
line, which is marketed and promoted through healthcare
practitioners in the medical
setting.
The Pure Leaf Oil
(consumer brand) and Seven Chakras (spa brand) lines are sold
through both online and brick & mortar retail
outlets.
Carniola’s
state-of-the-art manufacturing facility in Lacey, WA is operated by
Pure Health Products LLC (PHP), a wholly-owned subsidiary that
produces all of the Company’s CBD Isolate products, in addition to
providing private label and white label solutions for companies
looking to add high-quality CBD items to their offerings. Canbiola
is passionate about improving people’s lives and we take pride in
providing pure CBD products infused with organic and natural
ingredients. We want customers to know that they are buying
lab-tested, high-quality natural products at a great
price.
Canbiola’s Radical
Tactical LLC subsidiary produces CBD products in other forms
including vapes and gums.
Duramed Inc. and
DuramedNJ LLC, wholly-owned subsidiaries of Canbiola, further the
mission of providing innovative products designed to improve
people’s lives, aiming to reduce their use of opioid substances
through the utilization of durable medical devices. This product
line includes a wearable low-intensity ultrasound SAM (Sustained
Acoustic Medicine) device delivering multi-hour treatment intended
to accelerate healing, improve function for musculoskeletal
injuries (muscle, tendon, ligament) and reduce chronic pain
(without opioid pain medication).
With the creation of
its newest wholly-owned subsidiary, NY Hemp Depot LLC, Canbiola has
attained complete vertical integration, allowing it to fully
control the supply chain from seed to sale, develop customized
products and maximize profit margins. Through the utilization of
its newly acquired NY State Hemp Cultivation License, the Company
contracts with farmers throughout the state of NY to cultivate
specific strains of hemp, which is then processed into CBD Isolate
products to Canbiola’s exacting manufacturing standards and
specifications at the Company’s laboratory and production
facility.
The Company has signed
a definitive agreement to acquire 51% of the outstanding interests
in Green Grow; however, this transaction has not closed, which
closing is conditioned on several factors, including an audit of
Green Grow and completion of due diligence by the
Company.
For more information
about Canbiola, Inc., please visit: Canbiola.com
Forward-Looking
Statements
Forward-looking
statements and risks and uncertainties discussed in this letter
contain forward-looking statements. The words "anticipate,"
"believe," "estimate," "may," "intend," "expect," and similar
expressions identify such forward-looking statements. Expected,
actual results, performance, or achievements could differ
materially from those contemplated, expressed, or implied by the
forward-looking statements contained herein. Forward-looking
statements are subject to a number of risks and uncertainties,
including but not limited to, risks and uncertainties associated
with, among other things, the impact of economic, competitive, and
other factors affecting our operations, markets, products, and
performance. The matters discussed herein should not be construed
in any way, shape or manner of our future financial condition or
stock price.
Follow Canbiola on:
Twitter @CanbiolaHealth
Instagram @canbiola.inc or @canbiola_cbd or
@canbiola_medical_cbd
Investors and Media:
IR@canbiola.com
(516) 595-9544
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Aug 2024 to Sep 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Sep 2023 to Sep 2024